Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$0.21 - $1.24 $2,948 - $17,408
14,039 Added 156.98%
22,982 $6,000
Q4 2022

Feb 10, 2023

BUY
$0.99 - $2.91 $2,135 - $6,276
2,157 Added 31.79%
8,943 $11,000
Q3 2022

Nov 10, 2022

BUY
$0.13 - $2.27 $882 - $15,404
6,786 New
6,786 $14,000
Q2 2022

Aug 15, 2022

SELL
$1.54 - $6.48 $1,121 - $4,717
-728 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$3.67 - $7.63 $16,621 - $34,556
-4,529 Reduced 86.15%
728 $4,000
Q4 2021

Feb 14, 2022

BUY
$4.98 - $10.0 $26,179 - $52,570
5,257 New
5,257 $33,000

Others Institutions Holding PEAR

About Pear Therapeutics, Inc.


  • Ticker PEAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 138,768,992
  • Market Cap $1.39M
  • Description
  • Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...
More about PEAR
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.